tert-Butyl (3-bromo-2-methylpropyl)carbamate

Catalog No. :
ACAVZF216
CAS No. :
1510268-47-9
Molecular Formula :
C9H18BrNO2
Molecular Weight :
252.15

IUPAC Name:tert-butyl (3-bromo-2-methylpropyl)carbamate

tert-Butyl (3-bromo-2-methylpropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$203.00Login to see priceInquiryInquiry
100mg97%$292.00Login to see priceInquiryInquiry
250mg97%$410.00Login to see priceInquiryInquiry
1g97%$816.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-bromo-2-methylpropyl)carbamate
IUPAC Nametert-butyl (3-bromo-2-methylpropyl)carbamate
MDL No.MFCD24168790
Molecular FormulaC9H18BrNO2
Molecular Weight252.15
SMILESO=C(OC(C)(C)C)NCC(C)CBr
InChI KeyHYTMOLGBQNHTPA-UHFFFAOYSA-N
Synonymtert-butyl (3-bromo-2-methylpropyl)carbamate;Carbamic acid, N-(3-bromo-2-methylpropyl)-, 1,1-dimethylethyl ester;tert-Butyl N-(3-bromo-2-methylpropyl)carbamate
CAS No.1510268-47-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAVZF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQMGH045 route compound structure diagram
    ACQMGH045480451-99-8 In Stock
  4. Then
  5. ACAVZF216 route product structure diagram
    ACAVZF2161510268-47-9
Inquiry

2. ACAVZF216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVZF216 route product structure diagram
    ACAVZF2161510268-47-9
Inquiry

Comments (0)